Detemir as a once-daily basal insulin in type 2 diabetes

BACKGROUND: Insulin detemir, a long-acting basal insulin analog, is labeled for once-daily or twice-daily dosing in patients with type 1 (T1DM) or type 2 (T2DM) diabetes mellitus. Protocols for some earlier clinical studies of detemir evaluated twice-daily dosing, which may have generated the misper...

Descripción completa

Detalles Bibliográficos
Autor principal: Nelson, Scott E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262389/
https://www.ncbi.nlm.nih.gov/pubmed/22287854
http://dx.doi.org/10.2147/CPAA.S19539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262389/
https://www.ncbi.nlm.nih.gov/pubmed/22287854
http://dx.doi.org/10.2147/CPAA.S19539

Ejemplares similares